[PERSON]
Marc Voigt
Featured in 1 tracked story · first seen
Situations
Immutep immunotherapy development and funding
2 clusters · 4 sources · last updated
Latest: Immutep receives A$0.86 million Australian R&D tax incentive
Immutep is undergoing strategic and financial developments regarding its immunotherapy candidates, efti and IMP761. The company has refocused the development of eftilagimod alpha (efti) toward first-line head and neck ca